Cargando…

Development of a Flow Cytometry Assay to Predict Immune Checkpoint Blockade-Related Complications

Treatment of advanced melanoma with combined immune checkpoint inhibitor (ICI) therapy is complicated in up to 50% of cases by immune-related adverse events (irAE) that commonly include hepatitis, colitis and skin reactions. We previously reported that pre-therapy expansion of cytomegalovirus (CMV)-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schilling, Hannah-Lou, Glehr, Gunther, Kapinsky, Michael, Ahrens, Norbert, Riquelme, Paloma, Cordero, Laura, Bitterer, Florian, Schlitt, Hans J., Geissler, Edward K., Haferkamp, Sebastian, Hutchinson, James A., Kronenberg, Katharina
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637156/ https://www.ncbi.nlm.nih.gov/pubmed/34868015 http://dx.doi.org/10.3389/fimmu.2021.765644

Ejemplares similares

External validation of biomarkers for immune-related adverse events after immune checkpoint inhibition
por: Glehr, Gunther, et al.
Publicado: (2022)

Virus-specific memory T cell responses unmasked by immune checkpoint blockade cause hepatitis
por: Hutchinson, James A., et al.
Publicado: (2021)

Predicting Early Viral Control under Direct-Acting Antiviral Therapy for Chronic Hepatitis C Virus Using Pretreatment Immunological Markers
por: Hutchinson, James A., et al.
Publicado: (2018)

Identification and Isolation of Type II NKT Cell Subsets in Human Blood and Liver
por: Yang Zhou, Jordi, et al.
Publicado: (2022)

In question: the scientific value of preclinical safety pharmacology and toxicology studies with cell-based therapies
por: Broichhausen, Christiane, et al.
Publicado: (2014)

Immune profile of patients with peritoneal carcinomatosis selected for CRS-HIPEC therapy
por: Kleber, Julia, et al.
Publicado: (2023)

Advanced Flow Cytometry Assays for Immune Monitoring of CAR-T Cell Applications
por: Blache, Ulrich, et al.
Publicado: (2021)

Alternative approaches to myeloid suppressor cell therapy in transplantation: comparing regulatory macrophages to tolerogenic DCs and MDSCs
por: Riquelme, Paloma, et al.
Publicado: (2012)

DHRS9 Is a Stable Marker of Human Regulatory Macrophages
por: Riquelme, Paloma, et al.
Publicado: (2017)

TIGIT(+) iTregs elicited by human regulatory macrophages control T cell immunity
por: Riquelme, Paloma, et al.
Publicado: (2018)

Immunomodulation of Natural Killer Cell Function by Ribavirin Involves TYK-2 Activation and Subsequent Increased IFN-γ Secretion in the Context of In Vitro Hepatitis E Virus Infection
por: Kupke, Paul, et al.
Publicado: (2023)

Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
por: Schilling, Bastian, et al.
Publicado: (2015)

Postoperative cellular stress in the kidney is associated with an early systemic γδ T-cell immune cell response
por: Göcze, Ivan, et al.
Publicado: (2018)

Detection of Immune Checkpoint Receptors – A Current Challenge in Clinical Flow Cytometry
por: Shibru, Benjamin, et al.
Publicado: (2021)

Corticosteroids and immune checkpoint blockade
por: Min, Le, et al.
Publicado: (2015)

Immune checkpoint blockade in HIV
por: Gubser, Celine, et al.
Publicado: (2022)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

Standardization of cytokine flow cytometry assays
por: Maecker, Holden T, et al.
Publicado: (2005)

Using flow cytometry for mitochondrial assays
por: Monteiro, Lauar de Brito, et al.
Publicado: (2020)

High normal values of circulating immune cell subsets before surgery may be protective against development of postoperative acute kidney injury
por: Ehehalt, K, et al.
Publicado: (2015)

Update on checkpoint blockade therapy for lymphoma
por: Kline, Justin, et al.
Publicado: (2015)

Immune checkpoint blockade in ovarian cancer
por: Weiss, Lukas, et al.
Publicado: (2016)

LIGHTing tumor up for checkpoint blockade
por: Liang, Yong, et al.
Publicado: (2016)

Hallmarks of response to immune checkpoint blockade
por: Cogdill, Alexandria P, et al.
Publicado: (2017)

Immune-Checkpoint Blockade Therapy in Lymphoma
por: Kuzume, Ayumi, et al.
Publicado: (2020)

Activation of phagocytosis by immune checkpoint blockade
por: Li, Chia-Wei, et al.
Publicado: (2018)

Neutrophils in the era of immune checkpoint blockade
por: Faget, Julien, et al.
Publicado: (2021)

Immune Checkpoint Blockade for Metastatic Uveal Melanoma: Re-Induction following Resistance or Toxicity
por: Koch, Elias A. T., et al.
Publicado: (2022)

Laser Ablation Inductively Coupled Plasma Mass Spectrometry: An Emerging Technology for Multiparametric Analysis of Tissue Antigens
por: Hutchinson, Robert W., et al.
Publicado: (2015)

Potential Use of Gluconate in Cancer Therapy
por: Mycielska, Maria E., et al.
Publicado: (2019)

Trypan blue exclusion assay by flow cytometry
por: Avelar-Freitas, B.A., et al.
Publicado: (2014)

Inhibiting the inhibitors: Checkpoints blockade in solid tumors
por: Mavilio, Domenico, et al.
Publicado: (2013)

Immune-Checkpoint Blockade and Active Immunotherapy for Glioma
por: Ahn, Brian J., et al.
Publicado: (2013)

The Puzzle of Predicting Response to Immune Checkpoint Blockade
por: Onyshchenko, Mykola
Publicado: (2018)

Smoldering myocarditis following immune checkpoint blockade
por: Norwood, Timothy G., et al.
Publicado: (2017)

Diagnosis and Management of Hepatitis in Patients on Checkpoint Blockade
por: Reynolds, Kerry, et al.
Publicado: (2018)

The role of neoantigen in immune checkpoint blockade therapy
por: Yi, Ming, et al.
Publicado: (2018)

Predictive biomarkers for tumor immune checkpoint blockade
por: Tong, Mengting, et al.
Publicado: (2018)

Acquired Resistance to Immune Checkpoint Blockade Therapies
por: Zhao, Xianda, et al.
Publicado: (2020)

Checkpoint blockade therapy for functioning pituitary adenomas
por: Lorrey, Selena J., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m4bl90a25mtlor5n34o388sp1a